Citius Oncology (CTOR) Return on Capital Employed [ROCE] (2023 - 2026)
Citius Oncology's Return on Capital Employed [ROCE] came in at -99.34% for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 38.59 percentage points from -60.75% a year earlier and down 5.79 percentage points from the prior quarter.
Powered by 
Analysis
Citius Oncology (CTOR) Return on Capital Employed [ROCE] (2023 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Citius Oncology's Return on Capital Employed [ROCE] was -54.50%, down 9.57 percentage points from FY2024.
- Return on Capital Employed [ROCE] carries a three-year change of -54.09 percentage points (FY2022 to FY2025).
- Going back by fiscal year, Return on Capital Employed [ROCE] was -44.92% in FY2024, -1.74% in FY2023 (-1.34 pp) and -0.40% in FY2022.
- The fiscal Q3 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] in data going back to fiscal Q4 2023.
- Year-over-year, Return on Capital Employed [ROCE] has declined for three consecutive quarters.
- Business Quant data shows CTOR's Return on Capital Employed [ROCE] at -93.55% (Q2 2026), -36.84% (Q1 2026) and -50.23% (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Citius Oncology | 60.42 Mn | 30.00 Mn | 1.00 Mn | -99.34% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -99.34% |
| Mar 31, 2026 | -93.55% |
| Dec 31, 2025 | -36.84% |
| Sep 30, 2025 | -50.23% |
| Jun 30, 2025 | -60.75% |
| Mar 31, 2025 | -45.52% |
| Dec 31, 2024 | -36.06% |
| Jun 30, 2024 | -21.59% |
| Mar 31, 2024 | -9.46% |
| Dec 31, 2023 | -9.21% |
API Access
Citius Oncology Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CTOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "CTOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CTOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();